Innovative technology
Other than our complex generic development business area, we are also engaged in the development of innovative nanocarriers suitable to improve active substances´ solubility, biodistribution, toxicity and stability.
Nanomicelles
Our mission is to enhance lives through innovative and cost-effective pharmaceutical solutions. We are dedicated to researching, developing, and delivering high-quality innovative treatments that address urgent health needs globally. With a focus on collaboration, ethics, and sustainability, we strive to improve patient quality of life and advance medical science, prioritizing safety and well-being in everything we do.
Single-drug cargo
Simultaneous encapsulation
Surface decoration
Oncological drugs
GM1 Ganglioside nanomicelles can cargo Paclitaxel molecules
Increases the aqueous solubility of paclitaxel 6000 times
Protection of cargo from chemical and physiological degradation
Spontaneously bound to Serum Albumin
Oncological drugs
Currently applied to improve pharmacokynetic profile of NCE with proven in-vitro antitripanosomal activity
Ganglioside Nano-micelles
The unique external structure of gangliosides nano-micelles and their size allow to distribute them in the blood stream. Their peculiar interaction with the immune system produce a reactivation of the NK cells against the tumour cells.